Progress in the diagnosis and treatment of rapid eye movement sleep behavior disorder
10.12092/j.issn.1009-2501.2021.05.005
- Author:
Yuan YUAN
1
;
Yimeng ZHANG
1
;
Ning LI
1
;
Shuqin ZHAN
1
Author Information
1. Neurology of Xuanwu Hospital Capital Medical University
- Publication Type:Journal Article
- Keywords:
Auxiliary examination;
Neurodegenerative diseases;
Rapid eye movement sleep behavior disorder (RBD);
Treatment;
Α-synuclein
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2021;26(5):504-510
- CountryChina
- Language:Chinese
-
Abstract:
Rapid eye movement sleep behavior disorder (RBD) is characterized by dream enactment and rapid eye movement (REM) sleep without atonia. RBD is closely related to α-synucleinopathy disease, including Parkinson's disease (PD), Lewy body dementia (DLB) and multiple system atrophy (MSA). Many studies have discussed the markers, heredity, cognition, autonomic nervous function of RBD, and the predictive value for neurodegenerative diseases. This article reviews the research progress of early markers and treatments in recent years, and discusses future research directions.
